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Abstract: The therapeutic value of doxorubicin (DXO) as anticancer antibiotic is limited by its 
cardiotoxicity. This study aimed to investigate the protective effect of sesame oil against DXO-induced 
cardiotoxicity and oxidative stress. The administration of DXO (20 mg/kg) to Wister male rats, 
increased serum aspartate aminotransferase and creatine kinase activities (as cardiotoxicity indices) as 
well as cardiac malondialdehyde and protein carbonyl contents and catalase activity (as markers of 
oxidative stress). The cardiotoxicity damage in DOX treated rats was accompanied by histo 
pathological changes such as necrosis and apoptosis in cardiac tissues. These biochemical and 
histological disturbances were effectively attenuated on pretreatment with sesame oil (5ml/kg). These 
data suggest that sesame oil may be a suitable cardio protector during DOX treatment. 
  




 Doxorubicin[Adriamycin, (DOX)], an 
anthracycline antibiotic, is widely used as effective 
antineoplastic agent in the treatment of a variety of 
malignancies, including lymphoma, leukemia and solid 
tumors. However, DOX causes various toxic effects, 
the commonest of which is the dose-dependent 
cardiotoxicity[1]. Cardiotoxicity of DOX is mediated by 
the formation of free radicals and oxidative damage to 
cellular components[2]. DOX is enzymatically reduced 
to the DOX semiquinone radical. This semiquinone 
radical directly transfers its electron to molecular 
oxygen, generating a superoxide and hydrogen 
peroxide[3]. Because of free radical plays important 
roles in DOX-induce cardiotoxicity, it is logical to 
consider antioxidants as primary potential therapeutic 
agent to prevent such toxic effect. In fact, several 
compounds with antioxidant properties have been 
investigated with some degree of success. These 
include p-coumaric acid[4], garlic acid[2], erdosteine[5]  
and carvedilol[1]. 
 Sesame Oil  (SO) is extract from the plant 
Sesamum indicum (HS), family: Pedaliaceae[6]. SO 
offers protection over blood pressure, lipid profiles and 
lipid peroxidation in hypertensive patients[7]. SO 
attenuates oxidative stress and multiple organ failure 
triggered by endotoxin lipopolysaccharide in rats[8]. 
Sesamin and sesaminol are the major phenolic 
constituents of SO which have been reported to possess 
a broad spectrum of pharmacological effects including 
antimutagenic[9], 
antioxidant[10,11,12],antihypertensive[11],anti-
inflammatory[12] and antithrombotic[13].  
 This investigation was set to evaluate the protective 
effects of SO against DOX-induced cardiotoxicity in 
male rats and to study the mechanisms underlying these 
effects. 
 
MATERIALS AND METHODS 
 
Chemicals: The pure SO was purchased from Amoy 
Food Ltd. (Birmingham, England). DOX (Adriblastina) 
was purchased from Pharmacia Italia S.p.A. (Nerviana, 
Italy). USA. Thiobarbituric acid, Folin's reagent, 
epinephrine, SOD enzyme, H2O2 and bovine albumin 
were obtained from Sigma Chemical Co. (St. Louis, 
MO). The reagent kit for aspartate aminotransferase 
enzyme activity was purchased from BioMerieux (RCS 
Lyon, France). All other chemicals were obtained from 
local commercial suppliers. 
 
Animals: Adult male albino rats (150-200g) of the 
Wistar strain were obtained from the Animal House, 
UAE University, U.A.E. They were maintained on 
standard pellet diet and tap water ad libitum and were 
kept in polycarbonate cages with wood chip bedding 
under a 12 hr light/dark cycle and room temperature 22-
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24°C. Rats were acclimatized to the environment for 
one-week prior to experimental use. This study was 
approved by the Animal Ethics Committee, UAE 
University. 
.  
Treatment regime: DOX solution was freshly 
prepared, protected from light in a saline solution. SO 
was given orally by gavage at a volume of 5 ml/kg 
body weight. Rats were randomly divided into four 
groups (five rats each) and were subjected to the 
following treatments: In the DOX-treated group, 
animals were given a single intraperitoneal dose of 
DOX (20 mg/kg b.wt.), which has been used previously 
to induce heart toxicity in various animal species[5]. 
Animals of the third group were fed SO extract for 27 
days and heart toxicity induced by injected the same 
single dose DOX after three weeks of SO 
administration. The fourth group was treated with SO 
daily for 27 days. The control group was treated with 
distilled water (5 ml/kg b.wt.), for 27 days and injected 
with saline after three weeks of water administration. 
After 6 days of DOX and 27 days of oil and vehicle 
solution administrations, blood and hearts were 
collected from all groups. 
  
Sample preparation: Following diethyl ether 
anesthesia, blood was collected from the retro-orbital 
plexus. Following sacrifice hearts were removed and 
weighed. The organ weight/body weight ratio x 100 
was calculated and expressed as a relative organ 
weight. For histopathological examination, half of the 
heart was immediately fixed in 10% buffered formalin. 
For biochemical determination, another half of the heart 
was homogenized in ice-cold KCl (150 mM). The ratio 
of tissue weight to homogenization buffer was 1:10. 
From the latter, suitable dilutions for determination of 
the levels of protein carbonyl (P.carbonyl), 
malondialdehyde (MDA), total proteins and activity of 
catalase (CAT) were prepared in suitable different 
buffers. To obtain serum, blood was collected in 
centrifuge tubes and centrifuged in a refrigerated 
centrifuge (4°C) at 3000 r.p.m. for 20 min. 
 
Biochemical Assays and Histopathology: Activity of 
aspartate aminotransferase (AST) was determined in 
serum according to the method described by[14] and the 
assay was performed using BioMerieux reagent kit and 
following its instruction manual. Whereas, 
determination of MDA in biological materials, as 
described in[15], was based on its reaction with 
thiobarbituric acid (TBA) to form a pink complex with 
absorption maximum at 535 nm. 
CAT activity was determined by measuring the 
exponential disappearance of H2O2 at 240 nm and 
expressed in units/mg of protein as described by[16]. 
The total antioxidant capacity in heart was evaluated 
using ferric reducing antioxidant power (FRAP) assay. 
The FRAP assay was determined according to the 
method described by[17]. The FRAP assay measures the 
change in absorbance at 593 nm due to the formation of 
a blue colored ferrous- tripyridyltriazine complex from 
colorless oxidized ferric form by the action of electron 
donating antioxidants.  
Cardiac P.carbonyl contents were determined according 
to method of[18]. This method is based on 
spectrophotometric detection of the reaction of 2,4-
dinitophenylhydrazine with P.carbonyl to form protein 
hydrazones at 370nm. The results were expressed as 
nmol of carbonyl group per milligram of protein with 
molar extinction coefficient of 22000 M/cm. 
The total protein content of heart was determined 
according to the Lowry method as modified by[19]. 
Absorbance was recorded using Shimadzu recording 
spectrophotometer (UV-160) in all measurements.  
For the histological examinations, pieces of hearts were 
fixed in 10% neutral phosphate-buffered formalin, 
dehydrated in ethanol, cleared in xylene and embedded 
in paraffin Five-micrometer sections were stained with 
Hematoxylin and Eosin. The sections were examined 
under a Leica DMRB/E light microscope.  
 
Statistical Analysis:  SPSS (version 10) statistical 
program (SPSS Inc., Chicago, IL, USA) was used to 
carry out a one-way analysis of variance (ANOVA) on 
our data. When significant differences by ANOVA 
were detected, analysis of differences between the 
means of the treated and control groups were performed 
by using Dunnett's t test.  
 
RESULTS AND DISCUSSION 
 
Change in weight of heart and serum marker of heart 
damage: The relative weight of the organ is the percent 
of organ weight to the body weight. Treatment with 
DOX significantly (P<0.001) decreased relative  
 
Weight of the Heart (Figure 1a).  However, there was 
No significant change in relative weight of heart animal 
groups treated with SO alone or before DOX treatment. 
After treatment with DOX, The levels of serum marker 
of heart damage, AST significantly (P<0.001) increased 
compared to the control after. The treatment with SO 
alone did not show any significant changes in the AST 
activity, (Figure 1b).  While the treatment with SO 
before DOX treatment attenuated this increase in AST 
level.  




Fig. 1: Effect of SO on (a) relative weight of heart 
(%) and serum AST activity (u/dl) (b) in 
control-and DOX -treated rats. Each column 
represents the mean ± SE, for five rats in each 
group. *** P<0.001 vs C. Role of SO on 
oxidative stress : DOX treated rats showed a 
significant increase in the markers of oxidative 
stress, P.carbonyl (P<0.01) (Figure 2a) and 
MDA (P<0.05) (Figure 2b) and in CAT 
activity (P<0.01) (Figure 3a) and FRAP 
content (P<0.05) (Fig 3b)   
 
Histopathological effects of Doxorubicin[Adriamycin, 
(DOX)]: Figure 4 shows the light micrograph of control 
heart showing normal architecture. Severe 
degenerations of the myofibrils, with focal necrosis, 
vacuolated cytoplasm were clearly seen in the DOX-
treated group. DOX intoxication also induced 
eosinophilic cytoplasm, focal hemorrhage and with 
inflammatory cell infiltrations. Animals pretreated with 
SO showed better-preserved appearance of cardiac 
muscle fibers with slight degeneration and some 
leukocyte infiltration. Cardiac section of SO treated rats 
shows normal structure.  
 
Fig. 2: Effect of SO on cardiac (a) P.carbonyl  & (b) 
MDA levels (nmol / mg protein) in control- & 
DOX- treated rats. Each column represents the 
mean ± SE, for five rats in each group.*P < 
0.05; **P < 0.01 vs. C 
  
Fig. 3: Effect of SO on cardiac (a) CAT activity (u / 
mg protein)   and (b) FRAP content (nmol / 
mg protein) in control- and DOX- treated rats. 
Each column represents the mean ± SE, for 
five rats in each group. *P < 0.05; ***P < 
0.001 vs. control. 
 
There is a significant decrease in FRAP assay (P<0.05) 
(Figure 3b) in heart. While SO pretreatment completely 
prevented the elevation in P.carbonyl and MDA as well 
as the depletion in FRAP. Rats received SO alone did 
not show any changes in these oxidative stress markers. 
The treatment with DOX induced elevation (P<0.001) 
in cardiac CAT activity and the treatment with SO 
attenuated this effect (P<0.05) (Figure 3a).  
The protective effect of SO on cardiomyopathy of DOX 
was investigated in male Wister rats. To our 
knowledge, this is the first study that evaluates the 
protective effects of SO against myocardial damage 
induced by DOX in experimental animals. In this 
report, a single dose of DOX (20 mg/kg b wt) induced 
severe heart toxicity in adult male rats. Treatment with 
DOX has been shown to cause cardiomyopathy in 
various animal species[1,20,5]. The present results showed 
a significant reduction in the relative weight of heart 
and an increase in serum AST activity (a reliable 
biomarker of cardiac injury) after treatment with DOX. 
This DOX-induced myocardial damage was also 
confirmed by myocardial histopathological changes 
(Myocyte necrosis, degeneration and inflammatory cell 
infiltrations) similar to those reported in other 
studies[2,5,20].  
In this study, DOX-treated animals showed an elevation 
in myocardial MDA and P.carbonyl levels and 
depletion in total antioxidant capacity (FRAP) versus 
the control group, which are important indices of 
oxidative damage. A possible explanation for the 
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increased MDA and P.carbonyl concentrations might be 
the increased generation of reactive oxygen species 
(ROS) in DOX-induced tissues. ROS react with cardiac 
myocyte membrane and cause oxidative damage to 
cellular lipids, proteins and DNA and cause lipid and 
protein peroxidation and DNA fragmentation[21]. The 
role of oxidative stress, the elevation of oxidative 
macromolecules and the disturbance in antioxidant 
defenses in heart of DOX treated rats has been observed 
in previous studies[1,5,22]. The anthracycline ring 
structure of DOX has been shown to induce both 
enzymatic and non-enzymatic single-electron redox 
cycle liberation of ROS from molecular oxygen[3].   
Although cardiac total antioxidant capacity decreased in 
this study, CAT activity increased in DOX treated rats. 
This indicates the massive production of hydrogen 
peroxide in the myocardium and the significant role of 
hydrogen peroxide in DOX-induced cardio toxicity. 
The elevation in cardiac CAT activity has been reported 
in the previous studies[22] in male Wister rats treated 
with DOX. In fact, DOX functions as an anticancer 
drug through oxidative DNA damage and apoptosis by 
the DOX- induced direct hydrogen peroxide 
generation[23]. The redox-cycle of DOX in the presence 
of cytochrome P450 reductase and NADPH was 






Fig: 4 Photomicrograph of the heart of control (a) 
and SO- treated rats (b) showing the normal 
myofibrillar structure with striations and 
branched appearance. Hearts of DOX- treated 
rats (c & d) showing focal necrosis of muscle 
fibers with eosinophilia in the cytoplasm 
(arrows). Heart of DOX-treated rats also 
showing destruction of muscle fibers with 
Focal hemorrhage (arrowheads) and 
inflammatory cell infiltrations (stars). Group 
of rats pretreated with SO (e) & (f) before 
DOX exhibiting relatively normal myocardial 
cells with vascular dilatation and moderate 
degeneration of some fibril cells. (H&E, X 
200). 
 
Recently, much attention has been focused on the 
protective effects of antioxidants and naturally 
occurring substances against DOX-induced 
cardiotoxicity[4,2]. Administration of SO before DOX 
treatment clearly attenuated the cardio toxicity; 
normalized oxidative stress markers such as MDA, 
P.carbonyl and restored the total antioxidant capacity. 
SO also attenuated the increase in CAT activity. 
Accumulating evidence suggests that the protective 
effects of SO against oxidative damage could be 
attributed to its antioxidative properties[9,11,24]. The 
antioxidant activity of SO could be attributed to its 
phenolic lignans-type compounds namely sesamol, 
sesamin and sesaminol[6]. These antioxidant compounds 
have been found to possess antioxidant effects against 
oxidative damage induced by cupper in vitro study[10] 
and endotoxin lipopolysaccharide[8,24] and ischemia-
reperfusion[12] in rats. This prevention of the DOX-
induced oxidative stress damage in rats with SO 
supports the hypothesis that part of the mechanism of 
heart damage is attributed to the overproduction of free 
radicals.  
In conclusion, we showed that oxidative damage to 
heart contributes to the myocardial toxicity induced by 
DOX in male rats. These effects might be limited by the 
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